COVID-19 care disruptions cut U.S. one-year cancer survival, adding 17,390 deaths; see which cancers and groups were hit hardest.

FDA proposes MRD-negative and complete response endpoints to fast-track multiple myeloma drug approvals, pushing deeper molecular results over ORR.

PBM reform has finally made its way through Congress and was signed into law by President Donald Trump. Here are six things you need to know about the law

TrumpRx launched as a government-branded, direct-to-consumer discount platform for select brand-name drugs, but critics argue its cash-only savings may be limited, potentially misleading, and less cost-effective over time than traditional insurance or other programs.

Adolescent and young women are far less likely than men to receive HIV prevention medication despite meeting clinical eligibility and facing substantial HIV risk.

And what has it achieved? The meaning and achievements of managed care change with the times, the context, the goals — and in the eyes of the beholders.

Cigna reported 11% revenue growth for 2025. Company executives focused on several key issues in its call with investors: its settlement with the Federal Trade Commission, a transformation announced last year to move to a rebate-free model in pharmacy benefits, and a focus on patient affordability.

A meta-analysis of more than 20 phase 3 trials found no clear survival differences by sex or age in metastatic NSCLC but reported better outcomes for Asian patients and continued underrepresentation of Black patients.

Express Scripts agreed to overhaul its business model, ensuring patients pay the lowest available price for medications and reimbursing community pharmacies based on actual costs.